Clinical trial

Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic…

NCT00358527 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00358527
Title Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)
Official title A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Multicenter Study of Mometasone Furoate Nasal Spray on Sleep Disturbances and Daytime Somnolence in Subjects With Symptomatic Seasonal Allergic Rhinitis
Lead sponsor Organon and Co, Industry
Collaborators Integrated Therapeutics Group Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Seasonal Allergic Rhinitis
Intervention type Drug, Other
Interventions Mometasone Furoate Nasal Spray (MFNS), Placebo
Enrollment 401
Start date May 1, 2006
Primary completion Oct 1, 2006
Completion Nov 1, 2006
First posted Aug 1, 2006
Last update posted Feb 8, 2022

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies